XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.46%18.93B | 42.03%5.4B | -39.69%3.04B | -0.31%5.16B | 12.54%5.44B | -1.62%18.84B | -3.94%3.8B | 6.81%5.03B | -2.98%5.17B | -6.16%4.83B |
Total premiums earned | ---- | ---- | -4.26%3.33B | -6.94%3.33B | -6.29%3.46B | -5.22%14.12B | -3.86%3.39B | -1.67%3.48B | -5.07%3.57B | -9.59%3.69B |
-Net premiums written | ---- | ---- | -4.26%3.33B | -6.94%3.33B | -6.29%3.46B | -5.22%14.12B | -3.86%3.39B | -1.67%3.48B | -5.07%3.57B | -9.59%3.69B |
Net investment income | ---- | ---- | 45.85%1.39B | 102.47%820M | -18.31%785M | 32.30%3.28B | -23.25%964M | 123.76%951M | 11.88%405M | 119.91%961M |
Net realized gain loss on investments | ---- | ---- | -175.34%-55M | 54.55%-5M | -3,240.00%-167M | 126.58%84M | 135.53%27M | 529.41%73M | 92.31%-11M | 93.75%-5M |
Net foreign exchange gain loss | ---- | ---- | -439.79%-1.65B | -14.30%995M | 846.10%1.33B | -36.98%1.18B | 23.05%-611M | -32.45%485M | -10.62%1.16B | -78.07%141M |
Fee revenue and other income | ---- | ---- | -51.06%23M | -51.11%22M | -36.96%29M | -19.55%177M | -26.92%38M | -6.00%47M | -10.00%45M | -33.33%46M |
-Other income expense | ---- | ---- | -51.06%23M | -51.11%22M | -36.96%29M | -19.55%177M | -26.92%38M | -6.00%47M | -10.00%45M | -33.33%46M |
Total expenses | -7.87%12.51B | -7.00%3.27B | -8.80%2.94B | -6.27%3.14B | -6.36%3.27B | -4.92%13.58B | 2.69%3.51B | -4.58%3.23B | -7.62%3.35B | -9.47%3.49B |
Loss adjustment expense | -34.51%7.45B | -35.43%1.92B | -11.46%2.34B | -7.47%2.62B | -6.02%2.75B | -6.26%11.38B | 3.04%2.98B | -7.36%2.65B | -8.13%2.83B | -11.79%2.93B |
Policy acquisition expense | 520.10%5.06B | 546.63%1.35B | 6.47%214M | 2.97%208M | 4.88%215M | 3.03%816M | 7.22%208M | 3.61%201M | 2.54%202M | -0.97%205M |
Fees and commission expense | ---- | ---- | 0.40%251M | -8.21%246M | -8.93%255M | -5.82%1.05B | -5.90%255M | -6.37%250M | -3.94%268M | -6.67%280M |
Non-operating net interest income (expenses) | ---- | ---- | -2.04%-50M | 1.96%-50M | 2.08%-47M | 13.72%-195M | 14.55%-47M | 16.95%-49M | 7.27%-51M | 14.29%-48M |
-Interest expense-non operating | ---- | ---- | 2.04%50M | -1.96%50M | -2.08%47M | -13.72%195M | -14.55%47M | -16.95%49M | -7.27%51M | -14.29%48M |
Income before tax | 21.95%6.42B | 636.21%2.14B | -94.90%92M | 10.63%2.02B | 61.70%2.17B | 8.07%5.26B | -46.10%290M | 35.82%1.81B | 6.85%1.83B | 3.71%1.34B |
Income tax | 61.53%974M | 959.09%233M | -21.61%185M | 38.22%264M | 88.96%291M | 33.70%603M | -93.57%22M | 152.21%236M | -39.17%191M | -37.65%154M |
Earnings from equity interest net of tax | ||||||||||
Net income | 16.83%5.44B | 609.70%1.9B | -105.93%-93M | 7.41%1.76B | 58.16%1.88B | 5.45%4.66B | 36.73%268M | -11.90%1.57B | 17.22%1.63B | 13.47%1.19B |
Net Income continuous operations | 16.83%5.44B | 609.70%1.9B | -105.93%-93M | 7.41%1.76B | 58.16%1.88B | 5.45%4.66B | 36.73%268M | -11.90%1.57B | 17.22%1.63B | 13.47%1.19B |
Minority interest income | ||||||||||
Net income attributable to the parent company | 16.83%5.44B | 609.70%1.9B | -105.93%-93M | 7.41%1.76B | 58.16%1.88B | 5.45%4.66B | 36.73%268M | -11.90%1.57B | 17.22%1.63B | 13.47%1.19B |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 16.83%5.44B | 609.70%1.9B | -105.93%-93M | 7.41%1.76B | 58.16%1.88B | 5.45%4.66B | 36.73%268M | -11.90%1.57B | 17.22%1.63B | 13.47%1.19B |
Basic earnings per share | 23.94%9.68 | 647.83%3.44 | -106.42%-0.17 | 14.34%3.11 | 68.56%3.27 | 12.21%7.81 | 43.75%0.46 | -6.36%2.65 | 24.77%2.72 | 20.50%1.94 |
Diluted earnings per share | 23.78%9.63 | 643.48%3.42 | -106.44%-0.17 | 14.39%3.1 | 67.53%3.25 | 12.27%7.78 | 48.39%0.46 | -6.38%2.64 | 24.88%2.71 | 21.25%1.94 |
Dividend per share | 19.05%2 | 19.05%0.5 | 19.05%0.5 | 19.05%0.5 | 19.05%0.5 | 5.00%1.68 | 5.00%0.42 | 5.00%0.42 | 5.00%0.42 | 5.00%0.42 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |